Fineline Cube

Follow:
14455 Articles
Policy / Regulatory

NMPA Launches Pilot Program to Streamline Supplementary Drug Approval Process

Company

Organon Reports Q4 2023 Revenue Growth Driven by Women’s Health and Biosimilars

CompanyDrug

Roche’s Xolair Gains FDA Approval to Combat IgE-Mediated Food Allergies in Patients Aged 1 and Up

CompanyDrug

Ipsen Secures FDA Approval for Onivyde Regimen as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

CompanyDrug

FDA Approves Takeda’s Eohilia as First Oral Therapy for Eosinophilic Esophagitis in Patients Aged 11 and Up

CompanyDrug

Roche’s Piasky (Crovalimab) Secures NMPA Approval for Untreated Paroxysmal Nocturnal Hemoglobinuria

CompanyDrug

Roche Secures NMPA Approval for Rozlytrek to Treat Pediatric NTRK Fusion-Positive Tumors

CompanyDeals

Akeso Biopharma to Acquire 35% Stake in AD Pharmaceuticals for RMB 267 Million

Company

AstraZeneca Reports 6% Revenue Growth in 2023, Driven by Oncology and Diabetes Drug Sales

CompanyDeals

I-Mab to Become U.S.-Based Biotech, Divesting All China Assets for Up to $80 Million

CompanyDeals

AbbVie Expands Licensing Agreement for Innovative sCAR-T Platform with Scripps Research

Company

AstraZeneca Announces $300 Million Investment in Next-Gen Cell Therapies Manufacturing in the U.S.